Evidence map›Paper›PMID 28380011›Full record

ArticlePloS one2017

Increased inflammation is associated with islet autoimmunity and type 1 diabetes in the Diabetes Autoimmunity Study in the Young (DAISY).

Kathleen Waugh, Janet Snell-Bergeon, Aaron Michels, Fran Dong, Andrea K Steck, Brigitte I Frohnert, Jill M Norris, Marian Rewers

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 1 pooled it
4.0field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 1 synthesis or guideline pooled it, 33 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Potential role of type I interferon in the pathogenic process leading to type 1 diabetes.Current opinion in endocrinology, diabetes, and obesity · 2018
    Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Kathleen WaughBarbara Davis Center for Diabetes, University of Colorado Denver, Aurora, Colorado, United States of America.
Janet Snell-BergeonBarbara Davis Center for Diabetes, University of Colorado Denver, Aurora, Colorado, United States of America.
Aaron MichelsBarbara Davis Center for Diabetes, University of Colorado Denver, Aurora, Colorado, United States of America.
Fran DongBarbara Davis Center for Diabetes, University of Colorado Denver, Aurora, Colorado, United States of America.
Andrea K SteckBarbara Davis Center for Diabetes, University of Colorado Denver, Aurora, Colorado, United States of America.
Brigitte I FrohnertBarbara Davis Center for Diabetes, University of Colorado Denver, Aurora, Colorado, United States of America.
Jill M NorrisDepartment of Epidemiology, Colorado School of Public Health, University of Colorado, Aurora, Colorado, United States of America.
Marian RewersBarbara Davis Center for Diabetes, University of Colorado Denver, Aurora, Colorado, United States of America.
University of Colorado Denver · USColorado School of Public Health · US

Funding

Natural History of Pre-Diabetic Autoimmunity (DAISY)R01DK032493 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI REWERS, MARIAN J · 1986 to 2024
$9.3M
Multiple Autoantigens/Multiple Epitopes of Type 1DMR01DK032083 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI MICHELS, AARON W · 1986 to 2025
$6.9M
K12 Career DevelopmentK12DK094712 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI STECK, ANDREA · 2011 to 2021
$4.5M
Small Molecules Targeting Allele Specific MHC Class II PresentationK08DK095995 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI MICHELS, AARON W · 2012 to 2016
$762k
NIDDK NIH HHS K08 DK095995NIDDK NIH HHS K12 DK094712NIDDK NIH HHS R01 DK032083NIDDK NIH HHS R01 DK032493
6 · The paper itself

Abstract

backgroundType 1 diabetes (TID) is characterized by a loss of pancreatic islet beta cell function resulting in loss of insulin production. Genetic and environmental factors may trigger immune responses targeting beta cells thus generating islet antibodies (IA). Immune response pathways involve a cascade of events, initiated by cytokines and chemokines, producing inflammation which can result in tissue damage.

methodsA nested case-control study was performed to identify temporal changes in cytokine levels in 75 DAISY subjects: 25 diagnosed T1D, 25 persistent IA, and 25 controls. Serum samples were selected at four time points: (T1) earliest, (T2) just prior to IA, (T3) just after IA, and (T4) prior to T1D diagnosis or most recent. Cytokines (IFN-α2a, IL-6, IL-17, IL-1β, IP-10, MCP-1, IFN-γ, IL-1α, and IL-1ra) were measured using the Meso Scale Discovery system Human Custom Cytokine 9-Plex assay.

resultsMultivariate mixed models adjusting for HLA risk, first-degree relative status, age, and gender, showed MCP-1 and IFN-үto be significantly higher at T3 in T1D compared to IA subjects. At T4, IP-10 was significantly higher in IA subjects than controls.

conclusionsThis repeated measures nested case-control study identified increased inflammatory markers in IA children who developed T1D compared to IA children who had not progressed to clinical disease. It also showed increased inflammation in both T1D and IA children when compared to controls. Results suggest inflammation may be related to both the development of IA and progression to T1D.

Indexed as

AutoimmunityCase-Control StudiesChildChild, PreschoolCytokinesDiabetes Mellitus, Type 1FemaleHumansInfantInflammationIslets of LangerhansMaleCytokines

Identifiers

PMID28380011
PMCPMC5381877
OpenAlexW2604690511

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.